Soro A - Search Results

1

Absence of D147E mutation of CYP11B2 gene in hypertensive patients with increased corticosterone and aldosterone production.

Mulatero P, Glorioso N, Fallo F, Soro A, Morra di Cella S, Carra R, Filigheddu F, Veglio F. Mulatero P, et al. Among authors: soro a. Eur J Endocrinol. 2001 Apr;144(4):397-400. doi: 10.1530/eje.0.1440397. Eur J Endocrinol. 2001. PMID: 11275950 Clinical Trial.

2

11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.

Glorioso N, Filigheddu F, Parpaglia PP, Soro A, Troffa C, Argiolas G, Mulatero P. Glorioso N, et al. Among authors: soro a. Eur Heart J. 2005 Mar;26(5):498-504. doi: 10.1093/eurheartj/ehi070. Epub 2004 Dec 15. Eur Heart J. 2005. PMID: 15618035

3

Mildly raised corticosterone excretion rates in patients with essential hypertension.

Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Soro A, et al. J Hum Hypertens. 1995 Jun;9(6):391-3. J Hum Hypertens. 1995. PMID: 7473516

4

Interaction of alpha(1)-Na,K-ATPase and Na,K,2Cl-cotransporter genes in human essential hypertension.

Glorioso N, Filigheddu F, Troffa C, Soro A, Parpaglia PP, Tsikoudakis A, Myers RH, Herrera VL, Ruiz-Opazo N. Glorioso N, et al. Among authors: soro a. Hypertension. 2001 Aug;38(2):204-9. doi: 10.1161/01.hyp.38.2.204. Hypertension. 2001. PMID: 11509477

5

[Mineralocorticoids and hypertension].

Glorioso N, Soro A. Glorioso N, et al. Among authors: soro a. Cardiologia. 1998 Mar;43(3):241-51. Cardiologia. 1998. PMID: 9611851 Review. Italian. No abstract available.

6

The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.

Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, Lombardi C, Soro A, Dettori F, Parpaglia PP, Alibrandi MT, Cusi D, Bianchi G. Glorioso N, et al. Among authors: soro a. Hypertension. 1999 Oct;34(4 Pt 1):649-54. doi: 10.1161/01.hyp.34.4.649. Hypertension. 1999. PMID: 10523341

7

Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension.

Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Soro A, et al. Hypertension. 1995 Jan;25(1):67-70. doi: 10.1161/01.hyp.25.1.67. Hypertension. 1995. PMID: 7843756

8

Different sensitivity to hydrochlorothiazide and to potassium-canrenoate among essential hypertensive patients.

Glorioso N, Melis MG, Manunta P, Troffa C, Tonolo G, Soro A, Madeddu P, Pazzola A, Pala F, Cusi D, et al. Glorioso N, et al. Among authors: soro a. Clin Exp Hypertens. 1993;15 Suppl 1:187-96. Clin Exp Hypertens. 1993. PMID: 8513309 Clinical Trial.

9

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.

Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, Collatina S, Pahor M. Glorioso N, et al. Among authors: soro a. Hypertension. 1999 Dec;34(6):1281-6. doi: 10.1161/01.hyp.34.6.1281. Hypertension. 1999. PMID: 10601131 Clinical Trial.

10

Role of renal kallikrein in modulating the antihypertensive effect of a single oral dose of captopril in normal- and low-renin essential hypertensives.

Madeddu P, Oppes M, Rubattu S, Dessi'-Fulgheri P, Glorioso N, Soro A, Rappelli A. Madeddu P, et al. Among authors: soro a. J Hypertens. 1987 Dec;5(6):645-8. doi: 10.1097/00004872-198712000-00002. J Hypertens. 1987. PMID: 3323316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters